Legal & General Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-459
| Closed | -$4K | – | 3499 |
|
|
2022
Q2 | $4K | Sell |
459
-74
| -14% | -$645 | ﹤0.01% | 3465 |
|
|
2022
Q1 | $6K | Hold |
533
| – | – | ﹤0.01% | 3497 |
|
|
2021
Q4 | $17K | Hold |
533
| – | – | ﹤0.01% | 3334 |
|
|
2021
Q3 | $24K | Hold |
533
| – | – | ﹤0.01% | 3221 |
|
|
2021
Q2 | $29K | Buy |
533
+18
| +3% | +$979 | ﹤0.01% | 3154 |
|
|
2021
Q1 | $39K | Sell |
515
-1,226
| -70% | -$92.8K | ﹤0.01% | 2904 |
|
|
2020
Q4 | $189K | Buy |
1,741
+1,227
| +239% | +$133K | ﹤0.01% | 2439 |
|
|
2020
Q3 | $45K | Sell |
514
-170
| -25% | -$14.9K | ﹤0.01% | 2732 |
|
|
2020
Q2 | $73K | Buy |
684
+113
| +20% | +$12.1K | ﹤0.01% | 2614 |
|
|
2020
Q1 | $31K | Sell |
571
-145
| -20% | -$7.87K | ﹤0.01% | 2752 |
|
|
2019
Q4 | $49K | Buy |
716
+137
| +24% | +$9.38K | ﹤0.01% | 2820 |
|
|
2019
Q3 | $60K | Hold |
579
| – | – | ﹤0.01% | 2678 |
|
|
2019
Q2 | $46K | Buy |
579
+137
| +31% | +$10.9K | ﹤0.01% | 2811 |
|
|
2019
Q1 | $40K | Buy |
442
+77
| +21% | +$6.97K | ﹤0.01% | 2794 |
|
|
2018
Q4 | $20K | Hold |
365
| – | – | ﹤0.01% | 3088 |
|
|
2018
Q3 | $43K | Hold |
365
| – | – | ﹤0.01% | 2855 |
|
|
2018
Q2 | $37K | Buy |
365
+108
| +42% | +$10.9K | ﹤0.01% | 2908 |
|
|
2018
Q1 | $33K | Sell |
257
-103
| -29% | -$13.2K | ﹤0.01% | 2951 |
|
|
2017
Q4 | $35K | Buy |
360
+49
| +16% | +$4.76K | ﹤0.01% | 2987 |
|
|
2017
Q3 | $46K | Buy |
311
+92
| +42% | +$13.6K | ﹤0.01% | 2932 |
|
|
2017
Q2 | $36K | Buy |
219
+161
| +278% | +$26.5K | ﹤0.01% | 2993 |
|
|
2017
Q1 | $9K | Hold |
58
| – | – | ﹤0.01% | 3206 |
|
|
2016
Q4 | $7K | Buy |
+58
| New | +$7K | ﹤0.01% | 3267 |
|